The present invention is directed to benzamide containing compounds which inhibit the P2X7 receptor
本发明涉及含有抑制P2X7受体的苯甲酰胺类化合物。
Benzamides-containing compounds and their use in the treatment of epilepsy
申请人:MINDIMMUNE THERAPEUTICS, INC.
公开号:US10238654B2
公开(公告)日:2019-03-26
The present invention is directed to benzamide-containing compounds of formula I
or pharmaceutically acceptable salts thereof which inhibit the P2X7 receptor, and their use in the treatment of epilepsy.
本发明涉及式 I 的含苯甲酰胺化合物
或其药学上可接受的盐,它们能抑制 P2X7 受体,并可用于治疗癫痫。